Literature DB >> 28844109

Intratumoral Heterogeneity of Somatic Mutations for NRIP1, DOK1, ULK1, ULK2, DLGAP3, PARD3 and PRKCI in Colon Cancers.

Eun Ji Choi1, Ju Hwa Lee1, Min Sung Kim1, Sang Yong Song2, Nam Jin Yoo1, Sug Hyung Lee3.   

Abstract

Both NRIP1 and DOK1 genes are considered candidate tumor suppressor genes (TSGs). Also, cell polarity-related genes PARD3, PRKCI and DLGAP3, and autophagy-related genes ULK1 and ULK2 genes are considered to play crucial roles in tumorigenesis. The aim of our study was to find whether these genes were mutated in colorectal cancer (CRC). In a genome database, we observed that each of these genes harbored mononucleotide repeats in the coding sequences, which could be mutated in cancers with high microsatellite instability (MSI-H). For this, we studied 124 CRCs for the frameshift mutations of these genes and their intratumoral heterogeneity (ITH). NRIP1, DOK1, PARD3, PRKCI, DLGAP3, ULK1 and ULK2 harbored 18 (22.8%), 2 (2.5%), 2 (2.5%), 2 (2.5%), 5 (6.3%), 2 (2.5%) and 2 (2.5%) of 79 CRCs with MSI-H, respectively. However, we found no such mutations in microsatellite stable (MSS) cancers in the nucleotide repeats. We also studied ITH for the frameshift mutations in 16 cases of CRCs and detected that the frameshift mutations of NRIP1, DOK1, PARD3, PRKCI, DLGAP3, ULK1 and ULK2 showed regional ITH in 5 (31.3%), 2 (12.5%), 0 (0%), 0 (0%), 1 (6.3%), 1 (6.3%) and 3 (18.8%) cases, respectively. Our data exhibit that candidate cancer-related genes NRIP1, DOK1, PARD3, PRKCI, DLGAP3, ULK1 and ULK2 harbor mutational ITH as well as the frameshift mutations in CRC with MSI-H. Also, the results suggest that frameshift mutations of these genes might play a role in tumorigenesis through their inactivation in CRC.

Entities:  

Keywords:  Colon cancer; Frameshift mutation; Microsatellite instability; Tumor suppressor gene

Mesh:

Substances:

Year:  2017        PMID: 28844109     DOI: 10.1007/s12253-017-0297-0

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  21 in total

Review 1.  Biological and therapeutic impact of intratumor heterogeneity in cancer evolution.

Authors:  Nicholas McGranahan; Charles Swanton
Journal:  Cancer Cell       Date:  2015-01-12       Impact factor: 31.743

2.  Intraindividual genomic heterogeneity of high-grade serous carcinoma of the ovary and clinical utility of ascitic cancer cells for mutation profiling.

Authors:  Youn Jin Choi; Je-Keun Rhee; Soo Young Hur; Min Sung Kim; Sung Hak Lee; Yeun-Jun Chung; Tae-Min Kim; Sug Hyung Lee
Journal:  J Pathol       Date:  2016-11-21       Impact factor: 7.996

3.  Whole-exome sequencing identifies recurrent AKT1 mutations in sclerosing hemangioma of lung.

Authors:  Seung-Hyun Jung; Min Sung Kim; Sung-Hak Lee; Hyun-Chun Park; Hyun Joo Choi; Leeso Maeng; Ki Ouk Min; Jeana Kim; Tae In Park; Ok Ran Shin; Tae-Jung Kim; Haidong Xu; Kyo Young Lee; Tae-Min Kim; Sang Yong Song; Charles Lee; Yeun-Jun Chung; Sug Hyung Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

4.  Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers.

Authors:  Kathleen M Murphy; Shengle Zhang; Tanya Geiger; Michael J Hafez; Jeff Bacher; Karin D Berg; James R Eshleman
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

Review 5.  Intra-tumour heterogeneity: a looking glass for cancer?

Authors:  Andriy Marusyk; Vanessa Almendro; Kornelia Polyak
Journal:  Nat Rev Cancer       Date:  2012-04-19       Impact factor: 60.716

6.  The transcriptional coregulator RIP140 represses E2F1 activity and discriminates breast cancer subtypes.

Authors:  Aurélie Docquier; Pierre-Olivier Harmand; Samuel Fritsch; Maïa Chanrion; Jean-Marie Darbon; Vincent Cavaillès
Journal:  Clin Cancer Res       Date:  2010-04-21       Impact factor: 12.531

7.  Frameshift Mutations of HSPA4 and MED13 in Gastric and Colorectal Cancers.

Authors:  Yun Sol Jo; Mi Ryoung Choi; Sang Yong Song; Min Sung Kim; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2016-04-30       Impact factor: 3.201

8.  Regional bias of intratumoral genetic heterogeneity of nucleotide repeats in colon cancers with microsatellite instability.

Authors:  Youn Jin Choi; Min Sung Kim; Chang Hyeok An; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2014-04-21       Impact factor: 3.201

9.  Defective expression of polarity protein PAR-3 gene (PARD3) in esophageal squamous cell carcinoma.

Authors:  K Zen; K Yasui; Y Gen; O Dohi; N Wakabayashi; S Mitsufuji; Y Itoh; Y Zen; Y Nakanuma; M Taniwaki; T Okanoue; T Yoshikawa
Journal:  Oncogene       Date:  2009-06-08       Impact factor: 9.867

10.  Human protein kinase C Iota gene (PRKCI) is closely linked to the BTK gene in Xq21.3.

Authors:  R Mazzarella; A Ciccodicola; T Esposito; A Arcucci; C Migliaccio; C Jones; D Schlessinger; M D'Urso; M D'Esposito
Journal:  Genomics       Date:  1995-04-10       Impact factor: 5.736

View more
  7 in total

Review 1.  The Dual Roles of the Atypical Protein Kinase Cs in Cancer.

Authors:  Miguel Reina-Campos; Maria T Diaz-Meco; Jorge Moscat
Journal:  Cancer Cell       Date:  2019-08-29       Impact factor: 31.743

2.  LncRNA SLCO4A1-AS1 promotes colorectal cancer cell proliferation by enhancing autophagy via miR-508-3p/PARD3 axis.

Authors:  Zhaozhi Wang; Jianjun Jin
Journal:  Aging (Albany NY)       Date:  2019-07-16       Impact factor: 5.682

3.  Mutation profiling in eight cases of vagal paragangliomas.

Authors:  Anna V Kudryavtseva; Dmitry V Kalinin; Vladislav S Pavlov; Maria V Savvateeva; Maria S Fedorova; Elena A Pudova; Anastasiya A Kobelyatskaya; Alexander L Golovyuk; Zulfiya G Guvatova; George S Razmakhaev; Tatiana B Demidova; Sergey A Simanovsky; Elena N Slavnova; Andrey А Poloznikov; Andrey P Polyakov; Nataliya V Melnikova; Alexey A Dmitriev; George S Krasnov; Anastasiya V Snezhkina
Journal:  BMC Med Genomics       Date:  2020-09-18       Impact factor: 3.063

4.  Comprehensive analysis of DOK family genes expression, immune characteristics, and drug sensitivity in human tumors.

Authors:  Yongjun Guan; Man Li; Zhendong Qiu; Junhui Xu; Yichao Zhang; Ning Hu; Xuanzhe Zhang; Wenyi Guo; Jingping Yuan; Qiao Shi; Weixing Wang
Journal:  J Adv Res       Date:  2021-06-12       Impact factor: 10.479

5.  NRIP3 upregulation confers resistance to chemoradiotherapy in ESCC via RTF2 removal by accelerating ubiquitination and degradation of RTF2.

Authors:  Daqin Suo; Ling Wang; Tingting Zeng; Hui Zhang; Lei Li; Jinyun Liu; Jingping Yun; Xin-Yuan Guan; Yan Li
Journal:  Oncogenesis       Date:  2020-08-24       Impact factor: 7.485

Review 6.  Stress granules in colorectal cancer: Current knowledge and potential therapeutic applications.

Authors:  Noémie Legrand; Dan A Dixon; Cyril Sobolewski
Journal:  World J Gastroenterol       Date:  2020-09-21       Impact factor: 5.742

7.  Crosstalk between hypoxia-sensing ULK1/2 and YAP-driven glycolysis fuels pancreatic ductal adenocarcinoma development.

Authors:  Yu Jia; Hui-Yan Li; Ying Wang; Jue Wang; Jing-Wen Zhu; Yan-Yan Wei; Lu Lou; Xing Chen; Shi-Jing Mo
Journal:  Int J Biol Sci       Date:  2021-07-05       Impact factor: 6.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.